Minerva Neurosciences Inc (NERV) — Cash Flow-to-Debt Ratio
Minerva Neurosciences Inc (NERV) has a Cash Flow-to-Debt Ratio of -15.59x as of March 2026, meaning its operating cash flow of $-5.43 Billion could theoretically repay -16% of its total liabilities ($348.04 Million) in one year. Explore Minerva Neurosciences Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Minerva Neurosciences Inc Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Minerva Neurosciences Inc across 14 annual periods. Also explore NERV total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Minerva Neurosciences Inc (2012–2025)
Year-by-year debt coverage analysis for Minerva Neurosciences Inc. For market capitalisation and broader financial context, see Minerva Neurosciences Inc (NERV) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -56.60x | $-13.51 Billion | $238.72 Million | ▼ -18091.0% |
| 2024 | -0.31x | $-19.55 Million | $62.84 Million | ▼ -79.6% |
| 2023 | -0.17x | $-14.78 Million | $85.36 Million | ▲ +47.2% |
| 2022 | -0.33x | $-24.65 Million | $75.11 Million | ▲ +7.8% |
| 2021 | -0.36x | $-24.60 Million | $69.15 Million | ▲ +94.8% |
| 2020 | -6.81x | $-33.82 Million | $4.96 Million | ▼ -680.0% |
| 2019 | -0.87x | $-43.43 Million | $49.72 Million | ▼ -1.8% |
| 2018 | -0.86x | $-41.94 Million | $48.87 Million | ▼ -1545.7% |
| 2017 | 0.06x | $3.09 Million | $52.10 Million | ▲ +106.2% |
| 2016 | -0.95x | $-25.69 Million | $26.96 Million | ▼ -7.0% |
| 2015 | -0.89x | $-24.27 Million | $27.26 Million | ▲ +58.0% |
| 2014 | -2.12x | $-35.96 Million | $16.95 Million | ▼ -783.4% |
| 2013 | -0.24x | $-2.16 Million | $9.00 Million | ▲ +95.0% |
| 2012 | -4.77x | $-908.54K | $190.29K | — |